15-90102368-A-G

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2

The NM_002168.4(IDH2):​c.23T>C​(p.Val8Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000377 in 1,365,148 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.0021 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00017 ( 1 hom. )

Consequence

IDH2
NM_002168.4 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3B:1

Conservation

PhyloP100: -0.0680
Variant links:
Genes affected
IDH2 (HGNC:5383): (isocitrate dehydrogenase (NADP(+)) 2) Isocitrate dehydrogenases catalyze the oxidative decarboxylation of isocitrate to 2-oxoglutarate. These enzymes belong to two distinct subclasses, one of which utilizes NAD(+) as the electron acceptor and the other NADP(+). Five isocitrate dehydrogenases have been reported: three NAD(+)-dependent isocitrate dehydrogenases, which localize to the mitochondrial matrix, and two NADP(+)-dependent isocitrate dehydrogenases, one of which is mitochondrial and the other predominantly cytosolic. Each NADP(+)-dependent isozyme is a homodimer. The protein encoded by this gene is the NADP(+)-dependent isocitrate dehydrogenase found in the mitochondria. It plays a role in intermediary metabolism and energy production. This protein may tightly associate or interact with the pyruvate dehydrogenase complex. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014]
IDH2-DT (HGNC:53154): (IDH2 divergent transcript)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.005317807).
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00205 (310/151062) while in subpopulation AFR AF= 0.00691 (286/41384). AF 95% confidence interval is 0.00625. There are 1 homozygotes in gnomad4. There are 151 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 310 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IDH2NM_002168.4 linkc.23T>C p.Val8Ala missense_variant Exon 1 of 11 ENST00000330062.8 NP_002159.2 P48735-1
IDH2NM_001290114.2 linkc.-110T>C 5_prime_UTR_variant Exon 1 of 9 NP_001277043.1 P48735B4DSZ6
IDH2-DTNR_149130.1 linkn.237A>G non_coding_transcript_exon_variant Exon 1 of 3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IDH2ENST00000330062.8 linkc.23T>C p.Val8Ala missense_variant Exon 1 of 11 1 NM_002168.4 ENSP00000331897.4 P48735-1
IDH2ENST00000559482.5 linkc.23T>C p.Val8Ala missense_variant Exon 1 of 8 5 ENSP00000453016.1 H0YL11
IDH2ENST00000560061.1 linkn.23T>C non_coding_transcript_exon_variant Exon 1 of 9 2 ENSP00000453254.1 H0YLL5

Frequencies

GnomAD3 genomes
AF:
0.00206
AC:
311
AN:
150954
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00695
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00132
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000148
Gnomad OTH
AF:
0.00144
GnomAD3 exomes
AF:
0.0000965
AC:
7
AN:
72574
Hom.:
0
AF XY:
0.0000474
AC XY:
2
AN XY:
42192
show subpopulations
Gnomad AFR exome
AF:
0.00400
Gnomad AMR exome
AF:
0.000221
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000169
AC:
205
AN:
1214086
Hom.:
1
Cov.:
30
AF XY:
0.000151
AC XY:
90
AN XY:
595934
show subpopulations
Gnomad4 AFR exome
AF:
0.00660
Gnomad4 AMR exome
AF:
0.000604
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000102
Gnomad4 OTH exome
AF:
0.000478
GnomAD4 genome
AF:
0.00205
AC:
310
AN:
151062
Hom.:
1
Cov.:
32
AF XY:
0.00205
AC XY:
151
AN XY:
73808
show subpopulations
Gnomad4 AFR
AF:
0.00691
Gnomad4 AMR
AF:
0.00132
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000148
Gnomad4 OTH
AF:
0.00143
Alfa
AF:
0.00125
Hom.:
0
Bravo
AF:
0.00244
ESP6500AA
AF:
0.00210
AC:
6
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000468
AC:
4
Asia WGS
AF:
0.000613
AC:
2
AN:
3276

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:3Benign:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Mar 16, 2016
Mayo Clinic Laboratories, Mayo Clinic
Significance: Uncertain significance
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

D-2-hydroxyglutaric aciduria 2 Uncertain:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change replaces valine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 8 of the IDH2 protein (p.Val8Ala). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with IDH2-related conditions. ClinVar contains an entry for this variant (Variation ID: 559362). An algorithm developed to predict the effect of missense changes on protein structure and function outputs the following: PolyPhen-2: "Benign". The alanine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

IDH2-related disorder Benign:1
Jan 27, 2023
PreventionGenetics, part of Exact Sciences
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.087
BayesDel_addAF
Benign
-0.43
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
11
DANN
Benign
0.83
DEOGEN2
Benign
0.16
T;T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.056
N
LIST_S2
Benign
0.55
T;T
M_CAP
Pathogenic
0.59
D
MetaRNN
Benign
0.0053
T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
0.0
N;.
PrimateAI
Pathogenic
0.84
D
PROVEAN
Benign
0.44
N;N
REVEL
Benign
0.10
Sift
Benign
0.47
T;D
Sift4G
Benign
1.0
T;T
Polyphen
0.0
B;.
Vest4
0.12
MVP
0.56
MPC
0.62
ClinPred
0.0048
T
GERP RS
0.98
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.2
Varity_R
0.025
gMVP
0.31

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs369445642; hg19: chr15-90645600; COSMIC: COSV57478791; COSMIC: COSV57478791; API